Any stock, in context
VENUSREM · Healthcare
Venus Remedies Limited
Observation · 15 Oct 2026
How these are readVenus Remedies closed at ₹1,572.2 on 15 Oct 2026, 26.8% above its 200-day average and 4.8% below its 50-day average: above the long line, below the short one. It sits 18.7% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it fell 10.6%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- Trade-for-trade (BE series)
- vs 200-day
- +26.8%
- the long line
- vs 50-day
- −4.8%
- the short line
- From 52w high
- −18.7%
- ₹432.1₹2,044.3
- 3 months
- −10.6%
- sector median −2.7% · 109 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · BE series (trade-for-trade) · median traded value ₹5.10 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.13%
- 1W
- –
- 1M
- +1.73%
- 3M
- −10.60%
- YTD
- –
- 1Y
- +242.87%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.